This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medtronic Ardian Luxembourg S.a.r.l.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations by Mario Alvarado in Renal Neuromodulation
Introduction
Mario Alvarado is an accomplished inventor based in Santa Rosa, CA (US). He has made significant contributions to the field of medical technology, particularly in renal neuromodulation. His innovative work focuses on developing advanced catheter apparatuses that enhance treatment options for renal function.
Latest Patents
Alvarado holds 1 patent for his invention titled "Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods." This patent discloses a treatment device designed to achieve renal neuromodulation through intravascular access. The technology features a multi-electrode array that can be transformed between a low-profile delivery state and a deployed state. In the deployed state, the array expands radially to contact the interior wall of the renal blood vessel, allowing for the application of thermal and electrical energy to modulate neural fibers and improve renal function.
Career Highlights
Mario Alvarado is currently associated with Medtronic Ardian Luxembourg S.a.r.l., where he continues to innovate in the medical device sector. His work is pivotal in advancing treatment methodologies that can significantly impact patient care.
Collaborations
Alvarado collaborates with notable colleagues, including Kevin M Mauch and Robert J Beetel, who contribute to the development and refinement of his inventions.
Conclusion
Mario Alvarado's contributions to renal neuromodulation through his patented technologies exemplify the importance of innovation in medical treatments. His work not only enhances the understanding of renal function but also paves the way for improved therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
